Novo Nordisk A/S (NONOF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 03:47PM EDT
| Previous Close | 133.98 |
| Open | 133.13 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 128.05 - 135.00 |
| 52 Week Range | 74.70 - 140.32 |
| Volume | |
| Avg. Volume | 28,873 |
| Market Cap | 586.139B |
| Beta (5Y Monthly) | 0.19 |
| PE Ratio (TTM) | 45.66 |
| EPS (TTM) | 2.90 |
| Earnings Date | Aug 07, 2024 |
| Forward Dividend & Yield | 1.86 (1.40%) |
| Ex-Dividend Date | Mar 22, 2024 |
| 1y Target Est | N/A |
Investor's Business DailyMicrosoft Leads Five Stocks Near Buy Points As Market Flashes Green
Microsoft is near a buy point with the market rally flashing green. It's one of five stocks to watch.
ZacksPharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Bayer (BAYRY) releases Q1 results. J&J (JNJ) set to acquire private biotech, Proteologix, which will add atopic dermatitis candidates.
GlobeNewswireNovo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 17 May 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme initiate
© 2024 Yahoo. All rights reserved.